OR WAIT null SECS
Article
Earlier and proactive use is suggested for a variety of corneal diseases
Educate patients preoperatievly, evaluate their needs, and set appropriate expectations
Study: Neurolenses significantly impact reading speed
FDA approves biosimilar product ranibizumab-eqrn for retinal diseases
Aerie doses first patient in COMET-3 study for DED treatment
EyeCare4Kids names new executive director